Literature DB >> 31314968

Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.

Alexander C Flint1, Carol Conell1, Xiushui Ren1, Nader M Banki1, Sheila L Chan1, Vivek A Rao1, Ronald B Melles1, Deepak L Bhatt1.   

Abstract

BACKGROUND: The relationship between outpatient systolic and diastolic blood pressure and cardiovascular outcomes remains unclear and has been complicated by recently revised guidelines with two different thresholds (≥140/90 mm Hg and ≥130/80 mm Hg) for treating hypertension.
METHODS: Using data from 1.3 million adults in a general outpatient population, we performed a multivariable Cox survival analysis to determine the effect of the burden of systolic and diastolic hypertension on a composite outcome of myocardial infarction, ischemic stroke, or hemorrhagic stroke over a period of 8 years. The analysis controlled for demographic characteristics and coexisting conditions.
RESULTS: The burdens of systolic and diastolic hypertension each independently predicted adverse outcomes. In survival models, a continuous burden of systolic hypertension (≥140 mm Hg; hazard ratio per unit increase in z score, 1.18; 95% confidence interval [CI], 1.17 to 1.18) and diastolic hypertension (≥90 mm Hg; hazard ratio per unit increase in z score, 1.06; 95% CI, 1.06 to 1.07) independently predicted the composite outcome. Similar results were observed with the lower threshold of hypertension (≥130/80 mm Hg) and with systolic and diastolic blood pressures used as predictors without hypertension thresholds. A J-curve relation between diastolic blood pressure and outcomes was seen that was explained at least in part by age and other covariates and by a higher effect of systolic hypertension among persons in the lowest quartile of diastolic blood pressure.
CONCLUSIONS: Although systolic blood-pressure elevation had a greater effect on outcomes, both systolic and diastolic hypertension independently influenced the risk of adverse cardiovascular events, regardless of the definition of hypertension (≥140/90 mm Hg or ≥130/80 mm Hg). (Funded by the Kaiser Permanente Northern California Community Benefit Program.).
Copyright © 2019 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2019        PMID: 31314968     DOI: 10.1056/NEJMoa1803180

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  104 in total

1.  Isolated Diastolic Hypertension in the UK Biobank: Comparison of ACC/AHA and ESC/NICE Guideline Definitions.

Authors:  John W McEvoy; Nilanjan Chatterjee; Brian P McGrath; Prosenjit Kundu; Natalie Daya; Josef Coresh; Elizabeth Selvin
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

Review 2.  Prevalence of high blood pressure under 2017 ACC/AHA guidelines: a systematic review and meta-analysis.

Authors:  Peisheng Xiong; Zhixi Liu; Meijuan Xiong; Feng Xie
Journal:  J Hum Hypertens       Date:  2020-12-08       Impact factor: 3.012

Review 3.  Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin.

Authors:  Goran Koracevic; Milovan Stojanovic; Tomislav Kostic; Dragan Lovic; Miloje Tomasevic; Ruzica Jankovic-Tomasevic
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

4.  Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.

Authors:  Yukiko Imai; Takumi Hirata; Shigeyuki Saitoh; Toshiharu Ninomiya; Yoshihiro Miyamoto; Hirofumi Ohnishi; Yoshitaka Murakami; Hiroyasu Iso; Sachiko Tanaka; Katsuyuki Miura; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hirotsugu Ueshima; Shizukiyo Ishikawa; Tomonori Okamura
Journal:  Hypertens Res       Date:  2020-07-03       Impact factor: 3.872

5.  A new mechanism for the sex differences in angiotensin II-induced hypertension: the role of macula densa NOS1β-mediated tubuloglomerular feedback.

Authors:  Jie Zhang; Larry Qu; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Kun Jiang; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-12

6.  [Primary prevention of coronary heart disease : Evidence-based drug treatment].

Authors:  Franziska Mühleck; Ulrich Laufs
Journal:  Herz       Date:  2020-02       Impact factor: 1.443

7.  Ambulatory blood pressure monitoring and management of hypertension at a cardiac clinic in Kumasi Metropolis, Ghana.

Authors:  Ntani Suh Nsutebu; Isaac Kofi Owusu; Kwame Ohene Buabeng; Kwadwo Osei Bonsu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

8.  Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.

Authors:  John W McEvoy; Natalie Daya; Faisal Rahman; Ron C Hoogeveen; Roger S Blumenthal; Amil M Shah; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin
Journal:  JAMA       Date:  2020-01-28       Impact factor: 56.272

9.  Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.

Authors:  Christina Byrne; Manan Pareek; Muthiah Vaduganathan; Tor Biering-Sørensen; Arman Qamar; Ambarish Pandey; Thomas Bastholm Olesen; Michael Hecht Olsen; Deepak L Bhatt
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2020-11-01

10.  Association Between Pain, Blood Pressure, and Medication Intensification in Primary Care: an Observational Study.

Authors:  Elizabeth R Pfoh; Alexander M Chaitoff; Kathryn Martinez; Kaitlin Keenan; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2020-09-21       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.